Loblaw Co (L.TO):

Summary

• Loblaw (L.TO) was essentially unchanged over the five sessions ended August 28, 2026, slipping from C$60.53 to C$60.42.
• The five-day change was −C$0.11, or −0.18%, substantially smaller than the declines in Dollarama and Couche-Tard.
• Loblaw gained 1.7% on Monday as investors moved toward defensive grocery and pharmacy businesses after U.S.–Canada trade tensions escalated.
• Most of that gain was reversed Thursday as investors took profits and reduced consumer-staples exposure.
• No material company-specific announcement during the five days explains the movement; it was primarily defensive-sector rotation and tariff-related uncertainty.

Five-day movement

Date	Close	Daily move	Main interpretation
Aug. 21	C$60.53	Starting price	—
Aug. 24	C$61.56	+1.70%	Defensive buying after trade escalation
Aug. 25	C$61.25	−0.50%	Partial profit-taking
Aug. 26	C$61.45	+0.33%	Grocery and pharmacy stability
Aug. 27	C$60.61	−1.37%	Consumer-staples selling and reversal of Monday’s gain
Aug. 28	C$60.42	−0.31%	Broader market weakness
Five-session change	−C$0.11	−0.18%	Essentially flat

Loblaw historical prices

Key Drivers

1. Defensive demand supported Loblaw

The U.S.–Canada trade dispute escalated on August 24. Investors initially moved toward companies selling essential products rather than autos, discretionary merchandise or industrial goods.

Loblaw benefits from relatively stable demand across:

• Groceries.
• Prescription drugs.
• Pharmacy and healthcare services.
• Discount banners such as No Frills and Maxi.
• Private-label products, including No Name and President’s Choice.

This explains why Loblaw rose 1.7% on Monday while tariff-exposed manufacturers declined sharply.

2. Tariffs created both benefits and risks

Canada subsequently announced retaliatory tariffs on approximately 700 U.S. products, including prepared foods, cheese, seafood, toiletries and other consumer goods.

Potential negatives for Loblaw include:

• Higher wholesale food and merchandise costs.
• Supply-chain substitutions.
• Pressure on grocery margins if higher costs cannot be passed through.
• Greater consumer price sensitivity.

Potential positives include:

• Increased demand for Canadian products.
• More customers shifting toward discount stores and private labels.
• Stable grocery volumes despite weaker discretionary spending.

These opposing effects help explain why Loblaw finished the week approximately flat.

3. Thursday’s decline appears market-driven

Loblaw fell 1.37% on August 27, its largest daily decline of the week. Public news searches did not identify a material earnings release, guidance change or corporate announcement that would explain the move.

The most likely explanation is a combination of:

• Profit-taking after Monday’s defensive rally.
• Weakness across several TTCS constituents.
• Investors rotating toward technology and resource shares, which led the TSX on Thursday.
• Ongoing uncertainty over food-cost inflation.

This is an inference from market behaviour, not a confirmed company-specific catalyst.

4. Strong Q2 results provided support

Loblaw’s July 30 results remained constructive:

Q2 2026 measure	Result	YoY change
Revenue	C$15.27 billion	+4.1%
Adjusted EBITDA	Approximately C$1.9 billion	+5.1%
Adjusted diluted EPS	C$0.66	+11.9%
Adjusted EBITDA margin	12.6%	+10 basis points
2026 adjusted EPS outlook	High-single-digit growth	Reaffirmed

Loblaw Q2 results

These results reduced the likelihood of a major sell-off because they showed stable demand and continued earnings growth.

5. PC Financial sale creates a reporting transition

Q2 was Loblaw’s final quarter consolidating PC Financial. Beginning in Q3, Loblaw will instead recognize its proportionate share of EQB’s earnings.

This change could make year-over-year revenue and earnings comparisons less straightforward. However, it was already disclosed before the five-day period and was not a new catalyst last week.

Valuation Logic

Loblaw’s valuation reflects:

• Defensive grocery and pharmacy earnings.
• Strong private-label and discount-store positioning.
• Consistent share repurchases.
• Expected high-single-digit EPS growth.

The limitation is that defensive quality is already partly reflected in the price. Without a new earnings catalyst, the shares may remain range-bound when investors rotate toward faster-growing or commodity-sensitive sectors.

Scenarios

Scenario	Development	Indicative range
Bull	Tariff impact remains limited; discount and private-label demand strengthens	C$62–C$64
Base	Stable sales with modest food-cost pressure	C$59.50–C$62
Bear	Tariffs raise costs while political pressure limits price increases	C$56–C$59

These are analytical ranges, not price targets.

What would disprove the negative thesis?

• Food and pharmacy comparable sales accelerate.
• Loblaw maintains or expands retail margins despite tariffs.
• Private-label and discount-banner market share continues rising.
• Management reaffirms high-single-digit EPS growth after the PC Financial transition.
• The shares recover above approximately C$62–C$63 on strong volume.

Actionable Takeaways

Loblaw’s five-day performance was stable rather than meaningfully negative. Defensive grocery and pharmacy demand offset tariff-cost uncertainty and sector rotation. The next important evidence will be food inflation, comparable sales, retail margins and the first quarterly report following the PC Financial transaction.

Educational analysis only; no guarantee of future performance.